Literature DB >> 24823810

Inflammation programs self-reactive CD8+ T cells to acquire T-box-mediated effector function but does not prevent deletional tolerance.

Stephanie R Jackson1, Jinyun Yuan1, Melissa M Berrien-Elliott1, Collin L Chen1, Jennifer M Meyer1, Maureen J Donlin2, Ryan M Teague3.   

Abstract

CD8(+) T cells must detect foreign antigens and differentiate into effector cells to eliminate infections. But, when self-antigen is recognized instead, mechanisms of peripheral tolerance prevent acquisition of effector function to avoid autoimmunity. These distinct responses are influenced by inflammatory and regulatory clues from the tissue environment, but the mechanism(s) by which naive T cells interpret these signals to generate the appropriate immune response are unclear. The identification of the molecules operative in these cell-fate decisions is crucial for developing new treatment options for patients with cancer or autoimmunity, where manipulation of T cell activity is desired to alter the course of disease. With the use of an in vivo murine model to examine CD8(+) T cell responses to healthy self-tissue, we correlated self-tolerance with a failure to induce the T-box transcription factors T-bet and Eomes. However, inflammation associated with acute microbial infection induced T-bet and Eomes expression and promoted effector differentiation of self-reactive T cells under conditions that normally favor tolerance. In the context of a Listeria infection, these functional responses relied on elevated T-bet expression, independent of Eomes. Alternatively, infection with LCMV induced higher Eomes expression, which was sufficient in the absence of T-bet to promote effector cytokine production. Our results place T-box transcription factors at a molecular crossroads between CD8(+) T cell anergy and effector function upon recognition of peripheral self-antigen, and suggest that inflammation during T cell priming directs these distinct cellular responses.
© 2014 Society for Leukocyte Biology.

Entities:  

Keywords:  effector differentiation/immunity; immunotherapy; transcription factors

Mesh:

Substances:

Year:  2014        PMID: 24823810      PMCID: PMC4138202          DOI: 10.1189/jlb.1A0913-500RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  61 in total

Review 1.  Peripheral tolerance of CD8 T lymphocytes.

Authors:  William L Redmond; Linda A Sherman
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

2.  Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.

Authors:  Andrew M Intlekofer; Naofumi Takemoto; E John Wherry; Sarah A Longworth; John T Northrup; Vikram R Palanivel; Alan C Mullen; Christopher R Gasink; Susan M Kaech; Joseph D Miller; Laurent Gapin; Kenneth Ryan; Andreas P Russ; Tullia Lindsten; Jordan S Orange; Ananda W Goldrath; Rafi Ahmed; Steven L Reiner
Journal:  Nat Immunol       Date:  2005-11-06       Impact factor: 25.606

3.  Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival.

Authors:  P Bertolino; M C Trescol-Biémont; C Rabourdin-Combe
Journal:  Eur J Immunol       Date:  1998-01       Impact factor: 5.532

4.  Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors.

Authors:  W Chen; H Qin; B Chesebro; M A Cheever
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

Authors:  Y Agata; A Kawasaki; H Nishimura; Y Ishida; T Tsubata; H Yagita; T Honjo
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

6.  Cutting edge: immunity and IFN-gamma production during Listeria monocytogenes infection in the absence of T-bet.

Authors:  Sing Sing Way; Christopher B Wilson
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

7.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.

Authors:  Ganesh A Kolumam; Sunil Thomas; Lucas J Thompson; Jonathan Sprent; Kaja Murali-Krishna
Journal:  J Exp Med       Date:  2005-08-29       Impact factor: 14.307

8.  Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression.

Authors:  Gang Zhou; Zhengbin Lu; John D McCadden; Hyam I Levitsky; Aimee L Marson
Journal:  J Exp Med       Date:  2004-12-13       Impact factor: 14.307

9.  CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity.

Authors:  C Kurts; F R Carbone; M Barnden; E Blanas; J Allison; W R Heath; J F Miller
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

10.  T-bet is required for optimal proinflammatory CD4+ T-cell trafficking.

Authors:  Graham M Lord; Ravi M Rao; Hyeryun Choe; Brandon M Sullivan; Andrew H Lichtman; F William Luscinskas; Laurie H Glimcher
Journal:  Blood       Date:  2005-07-12       Impact factor: 22.113

View more
  7 in total

1.  T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model.

Authors:  David M Woods; Karrune V Woan; Fengdong Cheng; Andressa L Sodré; Dapeng Wang; Yongxia Wu; Zi Wang; Jie Chen; John Powers; Javier Pinilla-Ibarz; Yu Yu; Ya Zhang; Xuefeng Wu; Xiaoyan Zheng; Jeffrey Weber; Wayne W Hancock; Edward Seto; Alejandro Villagra; Xue-Zhong Yu; Eduardo M Sotomayor
Journal:  Blood       Date:  2017-05-26       Impact factor: 22.113

2.  Rescue of Tolerant CD8+ T Cells during Cancer Immunotherapy with IL2:Antibody Complexes.

Authors:  Lauryn E Klevorn; Melissa M Berrien-Elliott; Jinyun Yuan; Lindsey M Kuehm; Gregory D Felock; Sean A Crowe; Ryan M Teague
Journal:  Cancer Immunol Res       Date:  2016-11-01       Impact factor: 11.151

3.  Checkpoint blockade immunotherapy relies on T-bet but not Eomes to induce effector function in tumor-infiltrating CD8+ T cells.

Authors:  Melissa M Berrien-Elliott; Jinyun Yuan; Lauryn E Swier; Stephanie R Jackson; Collin L Chen; Maureen J Donlin; Ryan M Teague
Journal:  Cancer Immunol Res       Date:  2014-12-16       Impact factor: 11.151

4.  Genome-Wide DNA Methylation Profiling in CD8 T-Cells and Gamma Delta T-Cells of Asian Indian Patients With Takayasu Arteritis.

Authors:  Jayakanthan Kabeerdoss; Debashish Danda; Ruchika Goel; Hindhumathi Mohan; Sumita Danda; R Hal Scofield
Journal:  Front Cell Dev Biol       Date:  2022-06-23

Review 5.  Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature.

Authors:  Adina Stoian; Mircea Stoian; Zoltan Bajko; Smaranda Maier; Sebastian Andone; Roxana Adriana Cioflinc; Anca Motataianu; Laura Barcutean; Rodica Balasa
Journal:  Biomedicines       Date:  2022-03-25

6.  Neuropilin-1 expression is induced on tolerant self-reactive CD8+ T cells but is dispensable for the tolerant phenotype.

Authors:  Stephanie R Jackson; Melissa Berrien-Elliott; Jinyun Yuan; Eddy C Hsueh; Ryan M Teague
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

Review 7.  Natural Compounds with Potential to Modulate Cancer Therapies and Self-Reactive Immune Cells.

Authors:  Rhiane Moody; Kirsty Wilson; Anthony Jaworowski; Magdalena Plebanski
Journal:  Cancers (Basel)       Date:  2020-03-13       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.